E-Cigarette Poisonings Rising Quickly Among Young Children

Share this content:
E-Cigarette Poisonings Rising Quickly Among Young Children
E-Cigarette Poisonings Rising Quickly Among Young Children

MONDAY, May 9, 2016 (HealthDay News) -- Calls to poison control centers about young children's exposure to e-cigarettes have increased significantly in recent years, and those children who are exposed seem to suffer worse health effects than those exposed to traditional cigarettes, according to research published online May 9 in Pediatrics.

Researchers analyzed calls to the National Poison Data System about nicotine and tobacco products from January 2012 to April 2015. They focused on calls about children under the age of 6.

According to the researchers, 14.2 percent of calls were about exposure to e-cigarettes, compared to 60.1 percent about exposure to traditional cigarettes. In 91.6 percent of the e-cigarette cases, the children swallowed liquid nicotine. In 1.7 percent of the e-cigarette cases, the children suffered a moderate effect (71 cases) or a major effect (five cases). There was also one death. There was no effect in almost half the cases (46.6 percent) and a minor effect in 22.2 percent. The effect wasn't clear in the other cases. Children were admitted to health care facilities in 1.6 percent of cases, compared to 0.3 percent of cigarette exposure cases.

"The frequency of exposures to e-cigarettes and nicotine liquid among young children is increasing rapidly and severe outcomes are being reported," the authors conclude. "Prevention strategies include public education; appropriate product storage and use away from children; warning labels; and modifications of e-cigarette devices, e-liquid, and e-liquid containers and packaging to make them less appealing and less accessible to children."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Dupixent to Treat Eczema

FDA Approves Dupixent to Treat Eczema

Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation

Arm, Hand Function Restored in Tetraplegic Patient

Arm, Hand Function Restored in Tetraplegic Patient

Researchers utilized functional electric stimulation + intracortical brain-computer interface system

Total Knee Replacement Typically Has Minimal Impact on QoL

Total Knee Replacement Typically Has Minimal Impact on ...

Cost-effectiveness of the procedure could increase if restricted to more severely affected patients

is free, fast, and customized just for you!

Already a member?

Sign In Now »